Research Report on China Swine Fever Vaccine Industry, 2014-2018
|発行||China Research and Intelligence||商品コード||288687|
|出版日||ページ情報||英文 50 Pages
|中国における豚コレラワクチン産業の分析 Research Report on China Swine Fever Vaccine Industry, 2014-2018|
|出版日: 2014年09月17日||ページ情報: 英文 50 Pages||
China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.
Swine fever is considered a highly infectious disease that needs strict prevention, control and extermination. The swine fever vaccine is one of the necessary vaccines for pigs. Due to the mature technology of swine fever vaccines in China, most large-scale pig farms choose domestic vaccines instead of imported vaccines. There are 48 manufacturers of spleen neisseria vaccines and cell vaccines in China, including 32 for the former and 41 for the latter. Passaging cell vaccines used to be produced by Guangdong Winsun Pharmaceutical Co., Ltd. Through technology transfer, Dahuanong and Liaoning Yikang Biology Co.,Ltd. began to produce the products while Guangdong Winsun still leads in the industry.
According to the National Compulsory Immunization Plan of Animal Epidemic Diseases in China in 2013 issued by the Ministry of Agriculture of China, China implements compulsory immunity on four animal epidemic diseases including swine fever while the expenses on the vaccines are undertaken by the government.
With the increasing living standards of Chinese people, the demand for poultry meat keeps growing accordingly. However, as swine fever repeatedly occurs in China, either regional outbreak or scattered transmission, most of the cases are acute epidemic situations with high mortality rate. Meanwhile, some features of mild diseases add to the complexity of the swine fever epidemic situation. Under the circumstances, swine fever vaccines become increasingly popular while many competitive vaccine manufacturers began to develop more effective swine fever vaccines.
As Chinese economy develops and the living standards increase, the demand for pork will continue to grow, which promotes the development of pig raising industry. The market size of swine fever vaccines will continue to increase in China in the next few years. Many investment opportunities exist in China for manufacturers of animal vaccines.
Through this report, the readers can acquire the following information:
The Following Enterprises and People Are Recommended to Purchase This Report:
1.1. Definition of Swine Fever Vaccines